- Tytuł:
-
Treatment with low-dose, single-agent belantamab mafodotin is safe and provides long-term responses in heavily pretreated
multiple myeloma patients. - Autorzy:
- Źródło:
- European journal of haematology [Eur J Haematol] 2024 Mar; Vol. 112 (3), pp. 367-370. Date of Electronic Publication: 2023 Oct 26.
- Typ publikacji:
- Journal Article
- MeSH Terms:
-
Multiple Myeloma */diagnosisMultiple Myeloma */drug therapy
Antibodies, Monoclonal, Humanized*
Humans ; Aged ; Retrospective Studies ; Dexamethasone ; Antineoplastic Combined Chemotherapy Protocols/adverse effects